Window Shopping: Rheumatoid Arthritis Biosimilars On Show At ACR
Executive Summary
Clinicians in the US can’t buy in to anti-TNF biosimilars yet, but wave of equivalence data featured at American College of Rheumatology meeting gives them a chance to evaluate products before they hit the market.